收藏切换
The efficacy of tenofovir propofol versus entecavir in the treatment of chronic hepatitis B
收藏切换
Pengwei FAN, Xue YANG, Bin WANG, Huan XU, Jianzhong LIU*
World Clinical Drug | 2025, 46(10) : 1033 - 1038
Less
收藏切换
World Clinical Drug | 2025, 46(10): 1033-1038
• Article •
The efficacy of tenofovir propofol versus entecavir in the treatment of chronic hepatitis B
Full
Pengwei FAN, Xue YANG, Bin WANG, Huan XU, Jianzhong LIU*
Affiliations
  • Department of Laboratory, the Seventh Hospital of Wuhan, Wuhan 430061, Hubei Province, China
Published: 2025-10-10 doi: 10.13683/j.wph.2025.10.007
Outline
收藏切换
Objective

To compare the efficacy of tenofovir propofol and entecavir in the treatment of chronic hepatitis B(CHB) and their effects on serum Golgi protein(GP)73 and hepatitis B virus(HBV)-RNA.

Methods

A total of 96 eligible CHB patients admitted to our hospital from September 2023 to January 2025 were selected and randomly divided into the observation group and the control group, with 48 cases in each group. The control group was treated with entecavir dispersible tablets, while the observation group was treated with tenofovir profol fumarate tablets. Both groups were treated for 28 weeks. The clinical efficacy, GP73, HBV-RNA, hepatitis B surface antigen, HBV-DNA levels, liver function, liver fibrosis and the occurrence of adverse reactions were compared between the two groups.

Results

After treatment, there was a statistically significant difference in the total effective rate between the two groups(P<0.05). After treatment, the levels of GP73, HBV-RNA, hepatitis B surface antigen, HBV-DNA, alanine transaminase, aspartate transaminase, total bilirubin, laminin, procollagen type Ⅲ, type Ⅳ collagen, hyaluronic acid in the observation group were lower than those in the control group(P<0.05). There was no statistically significant difference in the occurrence of adverse reactions between the two groups(P>0.05).

Conclusion

Tenofovir propofol can effectively improve liver function in patients with CHB, has good safety, and has a good antiviral effect when used for a long time.

tenofovir propofol  /  entecavir  /  chronic hepatitis B  /  Golgi glycoprotein 73  /  hepatitis B virus-RNA
樊鹏威, 杨雪, 王斌, 徐欢, 刘建中. 丙酚替诺福韦对比恩替卡韦治疗慢性乙型肝炎效果. 世界临床药物, 2025 , 46 (10) : 1033 -1038 . DOI: 10.13683/j.wph.2025.10.007
Pengwei FAN, Xue YANG, Bin WANG, Huan XU, Jianzhong LIU. The efficacy of tenofovir propofol versus entecavir in the treatment of chronic hepatitis B[J]. World Clinical Drug, 2025 , 46 (10) : 1033 -1038 . DOI: 10.13683/j.wph.2025.10.007
Year 2025 volume 46 Issue 10
49
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.10.007
  • Receive Date:2025-04-14
  • Online Date:2026-11-09
  • Published:2025-10-10
Article Data
Affiliations
History
  • Received:2025-04-14
Affiliations
    Department of Laboratory, the Seventh Hospital of Wuhan, Wuhan 430061, Hubei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.10.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT